中国中医药信息杂志2017，Vol.24Issue(6)：1-5,5.DOI:10.3969/j.issn.1005-5304.2017.06.001
维药新药治疗高脂血症的临床研究指导原则(草案)
Clinical Research Guidelines for Treatment of Hyperlipidemia with New Uyghur Medicine (Draft)
摘要
Abstract
Based on medical ethics, retrospective multi-center study on medical records of Uyghur Medicine diagnosis and treatment program of hyperlipidemia was done and demographic, diagnostic, therapeutic, efficacy evaluation, nursing data and other information were collated. The main and secondary disease manifestations of hyperlipidemia were analyzed inductively and hyperlipidemia were divided into 4 types in Uyghur Medicine field, which were surplus and sticky Kan type, Chuchumal Balgham type, Gaisiman Balgham type, and Koygan Savda type. Therefore, Uighur Medicine syndrome type standards of hyperlipidemia were established. Treatment efficacy was evaluated with the combination of laboratory observation parameters and main and secondary disease manifestations. On this basis, in accordance with the technical requirements of the national medicine review, this study developed clinical research guidelines for the treatment of hyperlipidemia with new Uyghur Medicine (draft).关键词
高脂血症/维医药/诊断技术和方法/临床研究指导原则Key words
hyperlipidemia/Uyghur Medicine/diagnostic techniques and methods/clinical research guidelines分类
医药卫生引用本文复制引用
阿不都外力·阿不都克里木,白连省,李金凤,李治建,阿布都吉力力·阿布都艾尼,李攻戍,刘炳林,裴小静,周贝,斯拉甫·艾白,王平山,阿斯亚·吾甫尔,玉苏甫·买提努尔,莫合买提·乌斯曼,买尼沙·买买提,吐尔洪·阿西木,张宏..维药新药治疗高脂血症的临床研究指导原则(草案)[J].中国中医药信息杂志,2017,24(6):1-5,5.基金项目
新疆维吾尔自治区科技计划(201333101) （201333101）
